Easy to use app
- 100 free trades signup offer
- Easy-to-use platform
- Low fees
- Student and young investor discounts
DaVita HealthCare Partners is a medical care facilities business based in the US. DaVita HealthCare Partners shares (DVA) are listed on the NYSE and all prices are listed in US Dollars.
Its last market close was $151.85 – a decrease of 0.58% over the previous week. DaVita HealthCare Partners employs 70,000 staff and has a trailing 12-month revenue of around $12.7 billion.Our top picks for where to buy DaVita HealthCare Partners stock
Low margin rates
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
CA & US trading
- 6% cash rebate plus $2,200 in trading perks
- Low transaction fees
- Easy-to-use app
How to buy DaVita HealthCare Partners stock
- Choose a stock trading platform. Compare investment platforms.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – DVA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy DaVita HealthCare Partners stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
1 - 6 of 6
Finder Score for stock trading platforms
To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.
DaVita HealthCare Partners stock price (NYSE: DVA)
Use our graph to track the performance of DVA stocks over time.DaVita HealthCare Partners stocks at a glance
Information last updated 2024-12-19.
| Latest market close | $151.85 |
|---|---|
| 52-week range | $103.40 - $169.52 |
| 50-day moving average | $157.44 |
| 200-day moving average | $146.30 |
| Wall St. target price | $156.90 |
| PE ratio | 15.8147 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $9.28 |
Is it a good time to buy DaVita HealthCare Partners stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
DaVita HealthCare Partners price performance over time
Historical closes compared with the close of $151.85 from 2024-12-20
| 1 week (2024-12-13) | -0.58% |
|---|---|
| 1 month (2024-11-22) | -8.25% |
| 3 months (2024-09-20) | -7.41% |
| 6 months (2024-06-21) | 7.41% |
| 1 year (2023-12-22) | 45.55% |
|---|---|
| 2 years (2022-12-22) | 106.80% |
| 3 years (2021-12-22) | 38.45% |
| 5 years (2019-12-20) | 106.04% |
Is DaVita HealthCare Partners stock undervalued or overvalued?
Valuing DaVita HealthCare Partners stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of DaVita HealthCare Partners's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
DaVita HealthCare Partners's P/E ratio
DaVita HealthCare Partners's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, DaVita HealthCare Partners shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stock or simply that they're under-valued.
DaVita HealthCare Partners's PEG ratio
DaVita HealthCare Partners's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1059. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into DaVita HealthCare Partners's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
DaVita HealthCare Partners's EBITDA
DaVita HealthCare Partners's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.7 billion.
The EBITDA is a measure of a DaVita HealthCare Partners's overall financial performance and is widely used to measure a its profitability.
DaVita HealthCare Partners financials
| Revenue TTM | $12.7 billion |
|---|---|
| Operating margin TTM | 16.28% |
| Gross profit TTM | $3.4 billion |
| Return on assets TTM | 6.94% |
| Return on equity TTM | 44.88% |
| Profit margin | 6.53% |
| Book value | $4.68 |
| Market Capitalization | $12 billion |
TTM: trailing 12 months
DaVita HealthCare Partners stock dividends
We're not expecting DaVita HealthCare Partners to pay a dividend over the next 12 months.
Have DaVita HealthCare Partners's stocks ever split?
DaVita HealthCare Partners's stocks were split on a 2:1 basis on 8 September 2013 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your DaVita HealthCare Partners stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for DaVita HealthCare Partners stocks, which in turn could have impacted DaVita HealthCare Partners's stock price.
DaVita HealthCare Partners stock price volatility
Over the last 12 months, DaVita HealthCare Partners's stocks have ranged in value from as little as $103.4 up to $169.515. A popular way to gauge a stock's volatility is its "beta."
Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while DaVita HealthCare Partners's is 0.887. This would suggest that DaVita HealthCare Partners's stocks are less volatile than average (for this exchange).
DaVita HealthCare Partners overview
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc.
Frequently asked questions
What percentage of DaVita HealthCare Partners is owned by insiders or institutions?Currently 48.537% of DaVita HealthCare Partners stocks are held by insiders and 50.245% by institutions. How many people work for DaVita HealthCare Partners?
Latest data suggests 70,000 work at DaVita HealthCare Partners. When does the fiscal year end for DaVita HealthCare Partners?
DaVita HealthCare Partners's fiscal year ends in December. Where is DaVita HealthCare Partners based?
DaVita HealthCare Partners's address is: 2000 16th Street, Denver, CO, United States, 80202 What is DaVita HealthCare Partners's ISIN number?
DaVita HealthCare Partners's international securities identification number is: US23918K1088 What is DaVita HealthCare Partners's CUSIP number?
DaVita HealthCare Partners's Committee on Uniform Securities Identification Procedures number is: 89151A107
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…
What are stocks?
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
Read more…More resources on Finder
More guides on Finder
-
How to buy Raytheon Technologies (RTX) stocks
Steps to owning and managing Raytheon Technologies Corp, with 24-hour and historical pricing before you buy.
-
How to buy Gildan Activewear (GIL) stocks
Steps to owning and managing Gildan Activewear Inc., with 24-hour and historical pricing before you buy.
-
Best renewable energy stocks
These are the best renewable energy stocks to buy now in Canada.
-
Best stocks to buy right now in Canada
Finder’s unique algorithm found the 20 best TSX stocks to buy right now.
-
How to buy IL Makiage stock in Canada when it goes public
Everything we know about the IL Makiage IPO plus information on how to buy in.
-
How to buy ByteDance stock in Canada when it goes public
Everything we know about the ByteDance IPO plus information on how to buy in.
-
How to buy Auvik Networks stock in Canada when it goes public
Everything we know about the Auvik Networks IPO plus information on how to buy in.
-
How to buy goPuff stock in Canada when it goes public
Everything we know about the goPuff IPO plus information on how to buy in.
-
How to buy Universal Music Group (UMG) stock from Canada
If you live in Canada, you need a broker that provides access to foreign investments to buy Universal Music Group stock.
-
How to invest in the S&P 500 in Canada
Find out how to invest in the S&P 500 in Canada—one of the world’s most popular stock indices—to diversify your portfolio.